EP1904066
COMBINATIONS OF ESZOPICLONE AND TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPTHALENAMINE OR TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPTHALENAMINE, for treating MENOPAUSE, perimenopause AND COGNITIVE DISORDERS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
6.7.2006EP published:
23.5.2018EP application number:
06786496.7
EPO information:
European Patent Register
Max expiry date:
5.7.2026
Title:
COMBINATIONS OF ESZOPICLONE AND TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPTHALENAMINE OR TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPTHALENAMINE, for treating MENOPAUSE, perimenopause AND COGNITIVE DISORDERS
Timeline
Today
6.7.2006EP application
23.5.2018EP Publication
Owner
Name:
Sunovion Pharmaceuticals Inc.Address:
84 Waterford Drive, 01752, Marlborough, MA, US
Inventor
Name:
CARON, JudyAddress:
Westwood, Massachusetts, US
Name:
WESSEL, ThomasAddress:
Lenox, Massachusetts, US
Name:
LALJI, KarimAddress:
West Vancouver, BC V7S 1Z5, CA
Name:
VARNEY, MarkAddress:
Northborough, Massachusetts, US
Name:
BAKALE, Roger P.Address:
Shrewsbury, Massachusetts, US
Name:
SINGH, Surendra P.Address:
Shrewsbury, Massachusetts, US
Name:
WILKINSON, H. ScottAddress:
Westborough, Massachusetts, US
Name:
SU, XipingAddress:
Woodbridge, Connecticut, US
Name:
HAN, ZhengxuAddress:
Shrewsbury, Massachusetts, US
Name:
KOENIG, Stephan G.Address:
Shewsbury, Massachusetts, US
Priority
Number:
697013 PDate:
6.7.2005Country:
US
Classification
Categories:
A61K 31/135, A61K 31/4985, C07C 211/42, A61P 25/24, A61P 25/28, A61P 25/00